|
Loading...
Loading...
|
US Pharm. 2010;35(8):58.
For the first time, the Access to Medicine Index has given generic drug makers a separate ranking on its biannual index, and Ranbaxy Laboratories Ltd. and Cipla, both based in India, top the list. “The Access to Medicine Index independently assesses how individual pharmaceutical companies perform in promoting universal access to essential medicines, and is thus an important tool in improving performance,” said Carissa Etienne, MD, assistant director-general at the World Health Organization. Manufacturers were rated on seven factors, including access to medicine management, public policy and market influence, and product donations and philanthropy. The index was first published in 2008 by the Netherlands-based nonprofit Access to Medicine Foundation. Other generic manufacturers included in the 2010 index are Dr. Reddy's Laboratories Ltd., Mylan Inc., Sun Pharmaceuticals Ltd., and Teva Pharmaceutical Industries Ltd.
|
Loading...
Loading...
|
|
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date,
authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings,
including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations,
long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students,
other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn
Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE)
as a provider of continuing pharmacy education.
Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.
|